We adjust our estimates for IND-AS 116 and revise our gross margin assumptions downwards by 150bps in FY20E and 50bps in FY21E due to change in product mix. We expect revenues to grow at CAGR of 18.1% to Rs 16.4bn and adj PAT at 49.1% to Rs 708m over FY19-21E. At CMP, the stock is trading at 9.5FY20E and 4.9x FY21E EPS estimates of Rs 8.6 and Rs 16.5 respectively. We maintain our BUY rating on the stock with revised target price of Rs 116.
At CMP, the stock is trading at 12.7x FY20E and 6.6x FY21E earnings. Given robust revenue growth, high return ratios (RoE/RoCE of 22.6%/33.3% in FY21E) and free cash generation, we recommend investors to BUY and TP of Rs 132 (8.0x FY21E EPS).